CC
IONS icon

Centiva Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Centiva Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,700
Closed -$137K – 1656
2022
Q2 		$137K Buy
+3,700
New +$140K ﹤0.01% 1372
2020
Q1 		– Sell
-43,100
Closed -$2.6M – 764
2019
Q4 		$2.6M Hold
43,100
– – 0.13% 154
2019
Q3 		$2.58M Buy
+43,100
New +$2.81M 0.16% 139

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Centiva Capital's IONS Position: Q2 2024 in Review

Centiva Capital sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 8,474 shares — an estimated $367K sold.

Centiva Capital first reported a position in IONS in Q3 2019 and held it in 4 quarters. The position peaked at $1.75M in Q4 2019. 357 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • Centiva Capital reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Centiva Capital sold 8,474 Ionis Pharmaceuticals shares in Q2 2024, an estimated $367K.
  • Centiva Capital first reported a position in Ionis Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Centiva Capital's Ionis Pharmaceuticals position peaked at $1.75M in Q4 2019.
  • 357 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on Centiva Capital's 13F filing for Q2 2024, filed 14 Aug 2024.